Zaflart Tablet DEFLAZACORT

Introduction to Zaflart Tablet

Zaflart Tablet is a medication primarily used to treat certain muscle disorders. It is especially effective in managing conditions that involve muscle weakening and inflammation. This tablet is often prescribed to help improve muscle strength and function.

Composition of Zaflart Tablet

The active ingredient in Zaflart Tablet is Deflazacort. Deflazacort is a type of corticosteroid, which means it helps reduce inflammation and suppresses the immune system to provide relief from symptoms.

Uses of Zaflart Tablet

• Treatment of Duchenne muscular dystrophy (DMD) in children aged 5 and older.
• Reduction of inflammation in various muscle disorders.
• Suppression of the immune system to prevent further muscle damage.

Side effects of Zaflart Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Severe allergic reactions
• Sudden mood changes
• Severe stomach pain
• Vision problems

Precautions of Zaflart Tablet

Before taking Zaflart Tablet, inform your doctor if you have any allergies to its ingredients. Use with caution if you are pregnant or breastfeeding. Do not stop taking the medication suddenly, as it may lead to steroid withdrawal syndrome, which includes symptoms like loss of appetite, nausea, and tiredness.

How to Take Zaflart Tablet

• Take the tablet once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Zaflart Tablet

Zaflart Tablet is a valuable medication for managing muscle disorders, particularly Duchenne muscular dystrophy. While it offers significant benefits, it is important to be aware of its side effects and take necessary precautions. Always follow your doctor's instructions for the best results.